Associate Professor of Surgery
Duke University Medical Center
Dr. Michael Lidsky is an Associate Professor of Surgery within the Division of Surgical Oncology at Duke University. His clinical practice focuses on the surgical management of cancerous and pre-cancerous conditions of the liver, biliary tree, and pancreas. Dr. Lidsky also implemented and leads the Hepatic Artery Infusion (HAI) team at Duke, a rapidly growing program to deliver high-dose chemotherapy directly to the liver for patients with advanced primary and secondary liver cancers, including metastases from colorectal cancer and unresectable intrahepatic cholangiocarcinoma. In addition to Dr. Lidsky’s clinical practice, his research explores functional genomic and molecular mechanisms of tumorigenesis and chemoresistance in primary liver cancer. Specifically, he uses pre-clinical models of cholangiocarcinoma to recapitulate critical events in these tumors, so as to identify mechanisms driving tumor growth, metastasis, and resistance to chemotherapy, as well as inherent tumor-specific dependencies that can be therapeutically exploited. Ultimately, these models serve as a vehicle for the discovery of new or more efficacious therapies.
Prior to returning to Duke as Faculty in September 2018, Dr. Lidsky completed his surgical residency at Duke, followed by subspecialty training in complex general surgical oncology and hepatopancreatobiliary surgery at Memorial Sloan Kettering Cancer Center.